Cargando…
Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4(+) T cell activation and HIV-1 latency reversal
A proposed strategy to cure HIV uses latency-reversing agents (LRAs) to reactivate latent proviruses for purging HIV reservoirs. A variety of LRAs have been identified, but none has yet proven effective in reducing the reservoir size in vivo. Nanocarriers could address some major challenges by impro...
Autores principales: | Cao, Shijie, Slack, Sarah D., Levy, Claire N., Hughes, Sean M., Jiang, Yonghou, Yogodzinski, Christopher, Roychoudhury, Pavitra, Jerome, Keith R., Schiffer, Joshua T., Hladik, Florian, Woodrow, Kim A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436934/ https://www.ncbi.nlm.nih.gov/pubmed/30944862 http://dx.doi.org/10.1126/sciadv.aav6322 |
Ejemplares similares
-
HIV reservoir quantification by five-target multiplex droplet digital PCR
por: Levy, Claire N., et al.
Publicado: (2021) -
HIV reservoir quantification using cross-subtype multiplex ddPCR
por: Cassidy, Noah A.J., et al.
Publicado: (2021) -
Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir
por: Roychoudhury, Pavitra, et al.
Publicado: (2018) -
Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation
por: Hong, Soon-Seok, et al.
Publicado: (2016) -
Reanalysis of single-cell RNA sequencing data does not support herpes simplex virus 1 latency in non-neuronal ganglionic cells in mice
por: Ouwendijk, Werner J.D., et al.
Publicado: (2023)